Cargando…
Non-Viral Gene Delivery Systems for Treatment of Myocardial Infarction: Targeting Strategies and Cardiac Cell Modulation
Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality worldwide. Conventional therapies involving surgery or pharmacological strategies have shown limited therapeutic effects due to a lack of cardiac tissue repair. Gene therapy has opened an avenue for the treatment of cardi...
Autores principales: | Wang, Jieting, Yu, Luying, Zhou, Ao, Liu, Jie, Wang, Kai, Luo, Ying, Wang, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465433/ https://www.ncbi.nlm.nih.gov/pubmed/34575595 http://dx.doi.org/10.3390/pharmaceutics13091520 |
Ejemplares similares
-
Targeted NGF siRNA Delivery Attenuates Sympathetic Nerve Sprouting and Deteriorates Cardiac Dysfunction in Rats with Myocardial Infarction
por: Hu, Hesheng, et al.
Publicado: (2014) -
A Macrophage Membrane–Polymer Hybrid Biomimetic Nanoplatform for Therapeutic Delivery of Somatostatin Peptide to Chronic Pancreatitis
por: Wang, Fang, et al.
Publicado: (2022) -
Pharmacological Modulation of Cardiac Remodeling after Myocardial Infarction
por: Zhao, Wei, et al.
Publicado: (2020) -
mRNA therapy for myocardial infarction: A review of targets and delivery vehicles
por: Wang, Xinming, et al.
Publicado: (2022) -
Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction
por: Qi, Quan, et al.
Publicado: (2017)